generic propecia Among these SERMs, raloxifene may be the most attractive agent based on the evidence from five recent large trials Multiple Outcomes of Raloxifene Evaluation MORE, Continuing Outcomes Relevant to Evista CORE, Raloxifene Use for the Heart RUTH, Study of Tamoxifen and Raloxifene STAR, and Evista Versus Alendronate EVA
